Callos Andrew

Callos Andrew is listed in filings as EVP at Cytokinetics, Incorporated - Common Stock. This profile follows SEC Form 4 activity through Jun 1, 2026, including sale activity. Recent filings connect the profile to Cytokinetics, Incorporated - Common Stock (CYTK). The current snapshot covers public activity from Apr 7, 2025 to Jun 1, 2026. Reported amounts are shown as $1.1M to $875.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.